306
Participants
Start Date
March 24, 2022
Primary Completion Date
November 29, 2022
Study Completion Date
November 29, 2022
Test Product (tiotropium bromide inhalation powder)
A single dose of test product
18 mcg of Spiriva (Reference Product)
A single dose of reference product (Spiriva)
Placebo
A single dose of placebo
Phargentis SA (Central Contact), Barbengo
Investigational Site 204, Gaffney
Investigational Site 205, Union
Investigational Site 203, Anderson
Investigational Site 118, Jammu
Investigational Site 108, Sābarmatī
Investigational Site 119, Ahmedabad
Investigational Site 101, Ahmedabad
Investigational Site 120, Gandhinagar
Investigational Site 102, Vadodara
Investigational Site 107, Vadodara
Investigational Site 114, Surat
Investigational Site 111, Pune
Investigational Site 121, Nashik
Investigational Site 112, Nashik
Investigational Site 106, Nagpur
Investigational Site 105, Nagpur
Lead Sponsor
Phargentis SA
INDUSTRY